无缝合主动脉瓣置换术十年经验:随访期间生存与瓣膜耐久性的发生率及预测因素
该研究纳入本中心2010至2020年连续547例成功接受Perceval无缝合主动脉瓣置换术的患者并前瞻性超声随访。中位生存7.76年(95%CI 6.9-8.6),年龄、EuroSCORE II、基线透析和术后急性肾损伤≥2与更差生存显著相关;23例发生结构性瓣膜退化,年轻年龄是唯一预测因素。
要点
- 547例患者中位生存7.76年(95%CI 6.9-8.6),年龄、EuroSCORE II、基线透析和术后急性肾损伤≥2与更差生存显著相关。
- 23例发生结构性瓣膜退化,其中19例接受再干预,免于结构性瓣膜退化的中位时间为10.3年。
- 多变量Cox分析显示年龄(HR 0.89,95%CI 0.82-0.95;P<0.001)是结构性瓣膜退化的显著预测因素。
核心结论
- 无缝合瓣膜对于预期寿命10年的患者是可靠的主动脉瓣置换生物瓣膜。
- 植入时较年轻年龄是唯一与长期结构性瓣膜退化风险相关的因素。
研究设计与样本
- 回顾性纳入本中心2010至2020年所有连续成功接受Perceval无缝合主动脉瓣置换术的患者,共547例,并进行前瞻性超声心动图随访。
- 进行风险因素分析以评估与更差生存和生物瓣膜衰败相关的变量。
主要发现
- 研究人群平均年龄76.4(5.2)岁,51%为女性,平均logistic EuroSCORE为13%(11)。
- 中位生存7.76年(95%CI 6.9-8.6)。
- 风险因素分析确定年龄(HR 1.06,95%CI 1.03-1.11;P<0.001,每1岁)、EuroSCORE II(HR 1.08,95%CI 1.02-1.13;P<0.001,每1个百分点)、基线透析(HR 2.14,95%CI 1.4-4.4;P=0.038)和术后急性肾损伤≥2(HR 8.97,95%CI 4.58-17.6;P<0.001)为与更差生存显著相关的因素。
- 23例观察到结构性瓣膜退化,其中19例接受再干预,免于结构性瓣膜退化的中位时间为10.3年。
- 多变量Cox分析显示年龄(HR 0.89,95%CI 0.82-0.95;P<0.001)是结构性瓣膜退化的显著预测因素。
临床怎么用
- 作者认为无缝合瓣膜对于预期寿命10年的患者是可靠的主动脉瓣置换生物瓣膜。
- 作者认为植入时较年轻年龄是唯一与长期结构性瓣膜退化风险相关的因素。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Aortic valve replacement with a sutureless prosthesis [sutureless aortic valve replacement (Su-AVR)] is an option for patients with severe aortic valve stenosis. However, data regarding long-term outcomes and prosthesis durability are still lacking. METHODS: All consecutive patients who successfully underwent Su-AVR with the Perceval valve in our centre between 2010 and 2020 were included in the analysis and followed prospectively with echocardiography. Risk factor analysis was performed to assess variables associated with worse survival and bioprosthetic valve failure. RESULTS: Study population consisted of 547 patients: the mean age was 76.4 (5.2) years, 51% were female and the mean logistic EuroSCORE was 13% (11). The median survival was 7.76 years [95% confidence interval (CI) = 6.9-8.6]. Risk factor analysis identified age [hazard ratio (HR) 1.06, 95% CI 1.03-1.11; P < 0.001), EuroSCORE II (HR 1.08, 1.02-1.13; P < 0.001), baseline dialysis (HR 2.14, 95% CI 1.4-4.4; P = 0.038) and postoperative acute kidney injury ≥2 (HR 8.97, 95% CI 4.58-17.6; P < 0.001) as factors significantly correlated with worse survival. The reported HRs for age are per 1 year and for EuroSCORE II is 1 percentage point. Structural valve deterioration (SVD) was observed in 23 patients, of whom 19 underwent reintervention (median freedom from SVD 10.3 years). In multivariable Cox analysis, age (HR 0.89, 95% CI 0.82-0.95; P < 0.001) was found to be a significant predictor of SVD. Overall, 1.8% was referred for prosthetic valve endocarditis (confirmed or suspected) during follow-up. One patient showed moderate non-SVD and none developed prosthetic valve thrombosis. CONCLUSIONS: The sutureless valve represents a reliable bioprosthesis for aortic valve replacement in patients with a 10-year life expectancy. Younger age at the time of implant is the only factor associated with the risk of long-term SVD.
引用
- Pollari F, Mamdooh H, Hitzl W, et al. Ten years' experience with the sutureless aortic valve replacement: incidence and predictors for survival and valve durability at follow-up. Eur J Cardiothorac Surg. 2023. PMID: 36534823. doi:10.1093/ejcts/ezac572
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。